Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
A University of Denver virologist and biophysicist is one step closer to understanding how HIV spreads once it enters the ...
HIV stigma and discrimination continue to harm the lives of people living with HIV, and hinder efforts to stem the epidemic ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
The following is a summary of “Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
News Medical on MSN1d
Can nicotine improve cognitive function and inflammation in people with HIV?Research indicates smoking may improve cognitive control in HIV-positive individuals by lowering brain inflammation, ...
University of Pittsburgh researchers uncovered a surprising link between Alzheimer's disease and herpes simplex virus-1 ...
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback